top of page
Selzentry is classified as a CCR5 co-receptor antagonist. Selzentry, when used with other antiretroviral medications, is used for treatingCCR5-tropic HIV-1 infectionin adults and pediatric patients who weigh at least 2 kilograms. Fact Table Formula C29H41F2N5O License EU EMA,  US FDA Bioavailability 23% Legal status Rx-only Chemical Name Maraviroc Elimination half-life 14–18 hours Dosage (Strength) 300mg Pregnancy Consult Doctor Brands Selzentry Protein binding ~76% PubChem CID 3002977 MedlinePlus a607076 ChEBI 63608 ATC code J05AX09 DrugBank DB04835 KEGG D06670 Routes of administration By mouth

Selzentry (Maraviroc)

  • The dosage forms of Selzentry include tablets and an oral solution. The tablets come in 25 mg, 75 mg, 150 mg, and 300 mg strengths. The oral solution has a concentration of 20 mg/mL. Once you are prescribed and buy Selzentry, the Selzentry is dosed twice daily by mouth and can be taken with or without food. Selzentry must be taken with other antiretroviral medications. For pediatrics who weigh at least 2 kilograms, the dose should be given twice daily by mouth. The dose is based on body weight in kilograms and current antiretroviral medications. The dose should not be more than the recommended adult dose.
bottom of page